By Ajai Raj
The current state of clinical oncology gives many experts cause for optimism. Recent developments, including personalized medications and immunotherapy, show promise as the next generation of treatment. Before these new therapies can be given to patients, however, they must run the gauntlet of multiple clinical trials to verify their efficacy and safety. And, just as treatments are increasing in complexity, experts say the way trials are conducted must also adapt to meet the